Original Research

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer

Tremblay G, Chandiwana D, Dolph M, Hearnden J, Forsythe A, Monaco M

Cancer Management and Research 2018, 10:1319-1327

Published Date: 22 May 2018